Tapewire

Nasdaq · USD

SMMT

Summit Therapeutics Inc.

Export transactions ↓
Tapewire entity
3477
SEC CIK
0001599298
Parsed reports
130

Last 12 months

Inside the activity.

6 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202660
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 12, 2023 Filed Dec 13, 2023 22:11 UTC
Zanganeh MahkamDirector · Chief Executive Officer
PurchaseCommon Stock 5,000 $2.07 $10,350.00
Disclosure

SEC source: 0001599298-23-000103 · wk-form4_1702505507.xml · nonDerivative · entry 2

Zanganeh Mahkam · CIK 0001507650 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 494,814

F2 · shares: The Reporting Person purchased these shares in a single transaction on the open market.

Read SEC document
December 11, 2023 Filed Dec 13, 2023 22:11 UTC
Zanganeh MahkamDirector · Chief Executive Officer
OtherWarrant (right to buy) · Derivative 315,681 $0.00 Strike: $1.58 $0.00
Disclosure

SEC source: 0001599298-23-000103 · wk-form4_1702505507.xml · derivative · entry 5

Zanganeh Mahkam · CIK 0001507650 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee

Disclosed balance after: 0

Underlying: Common Stock · 315,681 shares

Expires 2029-12-24

F1 · shares: The Reporting Person exercised certain warrants to purchase shares of common stock in accordance with the terms of such warrants.

Read SEC document
December 11, 2023 Filed Dec 13, 2023 22:11 UTC
Zanganeh MahkamDirector · Chief Executive Officer
OtherWarrant (right to buy) · Derivative 489,814 $0.00 Strike: $1.44 $0.00
Disclosure

SEC source: 0001599298-23-000103 · wk-form4_1702505507.xml · derivative · entry 4

Zanganeh Mahkam · CIK 0001507650 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 489,814 shares

Expires 2025-06-30

F1 · shares: The Reporting Person exercised certain warrants to purchase shares of common stock in accordance with the terms of such warrants.

Read SEC document
December 11, 2023 Filed Dec 13, 2023 22:11 UTC
Zanganeh MahkamDirector · Chief Executive Officer
OtherCommon Stock 315,681 $1.58 $498,775.98
Disclosure

SEC source: 0001599298-23-000103 · wk-form4_1702505507.xml · nonDerivative · entry 3

Zanganeh Mahkam · CIK 0001507650 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee

Disclosed balance after: 24,889,479

F1 · shares: The Reporting Person exercised certain warrants to purchase shares of common stock in accordance with the terms of such warrants.

F3 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
December 11, 2023 Filed Dec 13, 2023 22:11 UTC
Zanganeh MahkamDirector · Chief Executive Officer
OtherCommon Stock 489,814 $1.44 $705,332.16
Disclosure

SEC source: 0001599298-23-000103 · wk-form4_1702505507.xml · nonDerivative · entry 1

Zanganeh Mahkam · CIK 0001507650 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 489,814

F1 · shares: The Reporting Person exercised certain warrants to purchase shares of common stock in accordance with the terms of such warrants.

Read SEC document
October 13, 2023 Filed Oct 16, 2023 20:08 UTC
Zanganeh MahkamDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 11,988,198 Not disclosed Strike: $1.68 Not disclosed
Disclosure

SEC source: 0001599298-23-000090 · wk-form4_1697486896.xml · derivative · entry 1

Zanganeh Mahkam · CIK 0001507650 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,988,198

Underlying: Common Stock · 11,988,198 shares

Expires 2033-10-13

F2 · price: Not applicable.

F1 · derivative.exercise_date: The option was granted on October 13, 2023. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on October 13, 2024. Note this does not include an additional 11,988,198 options which were granted on October 13, 2023 and are subject to the satisfaction of performance conditions based on market capitalization and revenue targets.

Read SEC document
October 13, 2023 Filed Oct 16, 2023 20:06 UTC
Soni Manmeet SinghDirector · Chief Operating Officer
GrantStock Option (right to buy) · Derivative 14,000,000 Not disclosed Strike: $1.68 Not disclosed
Disclosure

SEC source: 0001569769-23-000007 · wk-form4_1697486782.xml · derivative · entry 2

Soni Manmeet Singh · CIK 0001569769 · Director · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,000,000

Underlying: Common Stock · 14,000,000 shares

Expires 2033-10-13

F3 · price: Not applicable.

F2 · derivative.exercise_date: The option was granted on October 13, 2023. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on October 13, 2024. Note this does not include an additional 14,000,000 options which were granted on October 13, 2023 and are subject to the satisfaction of performance conditions based on market capitalization and revenue targets.

Read SEC document
October 13, 2023 Filed Oct 16, 2023 20:06 UTC
Soni Manmeet SinghDirector · Chief Operating Officer
PurchaseCommon Stock 2,976,190 $1.68 $4,999,999.20
Disclosure

SEC source: 0001569769-23-000007 · wk-form4_1697486782.xml · nonDerivative · entry 1

Soni Manmeet Singh · CIK 0001569769 · Director · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,976,190

F1 · shares: The Issuer entered into a securities purchase agreement with the Reporting Person, pursuant to which the Issuer agreed to issue and sell to the Reporting Person shares of the Issuer's Common Stock at a per share purchase price equal to $1.68.

F1 · balance_after: The Issuer entered into a securities purchase agreement with the Reporting Person, pursuant to which the Issuer agreed to issue and sell to the Reporting Person shares of the Issuer's Common Stock at a per share purchase price equal to $1.68.

Read SEC document
March 08, 2023 Filed Mar 9, 2023 02:31 UTC
Zanganeh MahkamDirector · Co-Chief Executive Officer
PurchaseCommon Stock 6,748,629 $1.05 $7,086,060.45
Disclosure

SEC source: 0001599298-23-000028 · wf-form4_167832905731524.xml · nonDerivative · entry 3

Zanganeh Mahkam · CIK 0001507650 · Director · Co-Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee.

Disclosed balance after: 9,884,095

F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.

F2 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 08, 2023 Filed Mar 9, 2023 02:31 UTC
Zanganeh MahkamDirector · Co-Chief Executive Officer
PurchaseCommon Stock 804,672 $1.05 $844,905.60
Disclosure

SEC source: 0001599298-23-000028 · wf-form4_167832905731524.xml · nonDerivative · entry 2

Zanganeh Mahkam · CIK 0001507650 · Director · Co-Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee.

Disclosed balance after: 1,178,529

F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.

F2 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 08, 2023 Filed Mar 9, 2023 02:31 UTC
Zanganeh MahkamDirector · Co-Chief Executive Officer
PurchaseCommon Stock 15,973,743 $1.05 $16,772,430.15
Disclosure

SEC source: 0001599298-23-000028 · wf-form4_167832905731524.xml · nonDerivative · entry 1

Zanganeh Mahkam · CIK 0001507650 · Director · Co-Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,395,269

F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.

Read SEC document
March 08, 2023 Filed Mar 13, 2023 22:27 UTC Amendment
Zanganeh MahkamDirector · Co-CEO & President
PurchaseCommon Stock 6,748,629 $1.05 $7,086,060.45
Disclosure

SEC source: 0001387131-23-003381 · zangeneh-form4a_030823.xml · nonDerivative · entry 2

Zanganeh Mahkam · CIK 0001507650 · Director · Co-CEO & President

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee.

Disclosed balance after: 9,884,095

F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.

F3 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 08, 2023 Filed Mar 13, 2023 22:27 UTC Amendment
Zanganeh MahkamDirector · Co-CEO & President
PurchaseCommon Stock 16,778,415 $1.05 $17,617,335.75
Disclosure

SEC source: 0001387131-23-003381 · zangeneh-form4a_030823.xml · nonDerivative · entry 1

Zanganeh Mahkam · CIK 0001507650 · Director · Co-CEO & President

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee.

Disclosed balance after: 24,573,798

F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.

F2 · shares: Includes the number of shares of Common Stock that were inadvertently previously disclosed as being held by Dr. Zanganeh personally, which are held by the Mahkam Zanganeh Revocable Trust. Dr. Zanganeh does not directly hold any shares personally, all of her shares are held through the Mahkam Zanganeh Revocable Trust.

F3 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 07, 2023 Filed Mar 8, 2023 22:24 UTC
Dhingra AnkurChief Financial Officer
PurchaseCommon Stock 196,362 $1.05 $206,180.10
Disclosure

SEC source: 0001849682-23-000004 · wf-form4_167831424008442.xml · nonDerivative · entry 2

Dhingra Ankur · CIK 0001849682 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Dhingra Family Revocable Trust

Disclosed balance after: 234,558

F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.

F2 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 07, 2023 Filed Feb 14, 2024 21:35 UTC
Xia YuDirector
PurchaseCommon Stock 21,523,530 $1.05 $22,599,706.50
Disclosure

SEC source: 0001999371-24-002333 · ownership.xml · nonDerivative · entry 1

Xia Yu · CIK 0001963544 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Akeso, Inc.

Disclosed balance after: 21,523,530

F1 · balance_after: 21,523,530 shares of the Issuer's Common Stock were acquired on March 7, 2023 through a rights offering.

F3 · ownership.nature: Akeso is the direct beneficial owner of the shares of the Issuer's Common Stock. Dr. Xia is a stockholder and exercises the right to vote approximately 28.9% of Akeso's ordinary shares, and serves as chairwoman, president and chief executive officer of Akeso. Dr. Xia disclaims beneficial ownership of the shares of Issuer's Common Stock beneficially owned by Akeso, except to the extent of her pecuniary interest.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:12 UTC
DUGGAN ROBERT WDirector · Chief Executive Officer
PurchaseCommon Stock 376,489,880 $1.05 $395,314,374.00
Disclosure

SEC source: 0001839882-23-006255 · dugganform4_030623.xml · nonDerivative · entry 1

DUGGAN ROBERT W · CIK 0001055919 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 552,354,161

F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.

Read SEC document
January 17, 2023 Filed Feb 14, 2024 21:35 UTC
Xia YuDirector
PurchaseCommon Stock 10,000,000 $2.51 $25,100,000.00
Disclosure

SEC source: 0001999371-24-002333 · ownership.xml · nonDerivative · entry 2

Xia Yu · CIK 0001963544 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Akeso, Inc.

Disclosed balance after: 10,000,000

F2 · balance_after: 10,000,000 shares of the Issuer's Common Stock were issued on January 17, 2023 in connection with the Collaboration and License Agreement with Akeso, Inc.("Akeso") pursuant to which the Issuer issued Akeso such shares.

F3 · ownership.nature: Akeso is the direct beneficial owner of the shares of the Issuer's Common Stock. Dr. Xia is a stockholder and exercises the right to vote approximately 28.9% of Akeso's ordinary shares, and serves as chairwoman, president and chief executive officer of Akeso. Dr. Xia disclaims beneficial ownership of the shares of Issuer's Common Stock beneficially owned by Akeso, except to the extent of her pecuniary interest.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 16:21 UTC GrantStock Option (right to buy) · Derivative 32,700 $1.67 Strike: $5.00 $54,609.00
Disclosure

SEC source: 0001507567-23-000003 · wf-form4_167295366118350.xml · derivative · entry 2

Booth Robert F. · CIK 0001507567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,700

Underlying: Common Stock · 32,700 shares

Expires 2033-01-03

F4 · price: The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $54,500.

F3 · derivative.exercise_date: The option was issued on January 3, 2023. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-employee director on each such vesting date.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 16:21 UTC GrantStock Option (right to buy) · Derivative 35,000 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001507567-23-000003 · wf-form4_167295366118350.xml · derivative · entry 1

Booth Robert F. · CIK 0001507567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2033-01-03

F2 · price: Not applicable.

F1 · derivative.exercise_date: The option was granted on January 3, 2023. The shares underlying the option shall vest in four equal annual installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-employee director on each such vesting date.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 16:12 UTC GrantStock Option (right to buy) · Derivative 44,400 $1.67 Strike: $5.00 $74,148.00
Disclosure

SEC source: 0001599298-23-000004 · wf-form4_167295314354996.xml · derivative · entry 2

Clark Kenneth A · CIK 0001561736 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,400

Underlying: Common Stock · 44,400 shares

Expires 2033-01-03

F4 · price: The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $74,000.

F3 · derivative.exercise_date: The option was issued on January 3, 2023. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-employee director on each such vesting date.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 16:12 UTC GrantStock Option (right to buy) · Derivative 35,000 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001599298-23-000004 · wf-form4_167295314354996.xml · derivative · entry 1

Clark Kenneth A · CIK 0001561736 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2033-01-03

F2 · price: Not applicable.

F1 · derivative.exercise_date: The option was granted on January 3, 2023. The shares underlying the option shall vest in four equal annual installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-employee director on each such vesting date.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:09 UTC GrantStock Option (right to buy) · Derivative 35,000 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001569769-23-000004 · wf-form4_167295295731969.xml · derivative · entry 1

Soni Manmeet Singh · CIK 0001569769 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2033-01-03

F2 · price: Not applicable.

F1 · derivative.exercise_date: The option was granted on January 3, 2023. The shares underlying the option shall vest in four equal annual installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-employee director on each such vesting date.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:17 UTC GrantStock Option (right to buy) · Derivative 16,350 $1.67 Strike: $5.00 $27,304.50
Disclosure

SEC source: 0001827015-23-000003 · wf-form4_167295342532705.xml · derivative · entry 2

Cesano Alessandra · CIK 0001827015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,350

Underlying: Common Stock · 16,350 shares

Expires 2033-01-03

F4 · price: The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $27,250.

F3 · derivative.exercise_date: The option was issued on January 3, 2023. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-employee director on each such vesting date.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:17 UTC GrantStock Option (right to buy) · Derivative 35,000 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001827015-23-000003 · wf-form4_167295342532705.xml · derivative · entry 1

Cesano Alessandra · CIK 0001827015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2033-01-03

F2 · price: Not applicable.

F1 · derivative.exercise_date: The option was granted on January 3, 2023. The shares underlying the option shall vest in four equal annual installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-employee director on each such vesting date.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:14 UTC GrantStock Option (right to buy) · Derivative 40,500 $1.67 Strike: $5.00 $67,635.00
Disclosure

SEC source: 0001599298-23-000006 · wf-form4_167295328081339.xml · derivative · entry 2

Mahatme Ujwala · CIK 0001823894 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,500

Underlying: Common Stock · 40,500 shares

Expires 2033-01-03

F4 · price: The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $67,500.

F3 · derivative.exercise_date: The option was issued on January 3, 2023. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-employee director on each such vesting date.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:14 UTC GrantStock Option (right to buy) · Derivative 35,000 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001599298-23-000006 · wf-form4_167295328081339.xml · derivative · entry 1

Mahatme Ujwala · CIK 0001823894 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2033-01-03

F2 · price: Not applicable.

F1 · derivative.exercise_date: The option was granted on January 3, 2023. The shares underlying the option shall vest in four equal annual installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-employee director on each such vesting date.

Read SEC document
December 06, 2022 Filed Dec 8, 2022 23:28 UTC
DUGGAN ROBERT WDirector · Chief Executive Officer
OtherCommon Stock 9,346,434 Not disclosed Not disclosed
Disclosure

SEC source: 0001387131-22-012236 · duggan-form4_120622.xml · nonDerivative · entry 1

DUGGAN ROBERT W · CIK 0001055919 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,879,226

F1 · kind: 9,346,434 shares of Common Stock were issued to the Reporting Person as payment of interest in connection with a Note Purchase Agreement, dated December 6, 2022, by and among the Issuer, the Reporting Person and Dr. Maky Zanganeh. The determination of the number of shares of Common Stock to be issued to the Reporting Person was based on a per share price of $0.79.

F1 · price: 9,346,434 shares of Common Stock were issued to the Reporting Person as payment of interest in connection with a Note Purchase Agreement, dated December 6, 2022, by and among the Issuer, the Reporting Person and Dr. Maky Zanganeh. The determination of the number of shares of Common Stock to be issued to the Reporting Person was based on a per share price of $0.79.

Read SEC document
December 06, 2022 Filed Dec 9, 2022 23:22 UTC
Zanganeh MahkamDirector · Co-CEO & President
OtherCommon Stock 373,857 Not disclosed Not disclosed
Disclosure

SEC source: 0001387131-22-012291 · zangeneh-form4_120622.xml · nonDerivative · entry 1

Zanganeh Mahkam · CIK 0001507650 · Director · Co-CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,930,849

F1 · kind: 373,857 shares of Common Stock were issued to the Reporting Person as payment of interest in connection with a Note Purchase Agreement, dated December 6, 2022, by and among the Issuer, the Reporting Person and Robert W. Duggan. The determination of the number of shares of Common Stock to be issued to the Reporting Person was based on a per share price of $0.79.

F1 · price: 373,857 shares of Common Stock were issued to the Reporting Person as payment of interest in connection with a Note Purchase Agreement, dated December 6, 2022, by and among the Issuer, the Reporting Person and Robert W. Duggan. The determination of the number of shares of Common Stock to be issued to the Reporting Person was based on a per share price of $0.79.

Read SEC document
November 15, 2022 Filed Nov 17, 2022 21:27 UTC GrantStock Option (right to buy) · Derivative 4,166 Not disclosed Strike: $1.09 Not disclosed
Disclosure

SEC source: 0001599298-22-000127 · wf-form4_166872044673174.xml · derivative · entry 2

Cesano Alessandra · CIK 0001827015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,166

Underlying: Common Stock · 4,166 shares

Expires 2032-11-15

F2 · price: Not applicable.

F3 · derivative.exercise_date: The option was granted on November 15, 2022 and represents a pro rata amount of the annual 25,000 option board grant based approximately on the number of days the Reporting Person is anticipated to serve as a director. The shares underlying the option are scheduled to vest in full on December 31, 2022.

Read SEC document
November 15, 2022 Filed Nov 17, 2022 21:27 UTC GrantStock Option (right to buy) · Derivative 200,000 Not disclosed Strike: $1.09 Not disclosed
Disclosure

SEC source: 0001599298-22-000127 · wf-form4_166872044673174.xml · derivative · entry 1

Cesano Alessandra · CIK 0001827015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2032-11-15

F2 · price: Not applicable.

F1 · derivative.exercise_date: The option was granted on November 15, 2022. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on November 15, 2023.

Read SEC document
September 28, 2022 Filed Oct 3, 2022 16:50 UTC GrantStock Option (right to buy) · Derivative 6,250 Not disclosed Strike: $1.21 Not disclosed
Disclosure

SEC source: 0001839882-22-022703 · booth-form4_093022.xml · derivative · entry 2

Booth Robert F. · CIK 0001507567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,250

Underlying: Common Stock · 6,250 shares

Expires 2032-09-28

F3 · price: Not applicable.

F2 · derivative.exercise_date: The option was granted on September 28, 2022 and represents a pro rata amount of the annual 25,000 option board grant based approximately on the number of days the Reporting Person is anticipated to serve as a director. The shares underlying the option are scheduled to vest in full on December 31, 2022.

Read SEC document
September 28, 2022 Filed Oct 3, 2022 16:50 UTC GrantStock Option (right to buy) · Derivative 200,000 Not disclosed Strike: $1.21 Not disclosed
Disclosure

SEC source: 0001839882-22-022703 · booth-form4_093022.xml · derivative · entry 1

Booth Robert F. · CIK 0001507567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2032-09-28

F3 · price: Not applicable.

F1 · derivative.exercise_date: The option was granted on September 28, 2022. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on September 28, 2023.

Read SEC document
August 16, 2022 Filed Aug 17, 2022 20:49 UTC
Dhingra AnkurChief Financial Officer
PurchaseCommon Stock 24,658 $0.97 $23,918.26
Disclosure

SEC source: 0001599298-22-000102 · wf-form4_166076931714249.xml · nonDerivative · entry 2

Dhingra Ankur · CIK 0001849682 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Dhingra Family Revocable Trust

Disclosed balance after: 38,196

F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.

F2 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
August 16, 2022 Filed Aug 17, 2022 20:49 UTC
Dhingra AnkurChief Financial Officer
PurchaseCommon Stock 11,557 $0.97 $11,210.29
Disclosure

SEC source: 0001599298-22-000102 · wf-form4_166076931714249.xml · nonDerivative · entry 1

Dhingra Ankur · CIK 0001849682 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,057

F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.

Read SEC document
August 16, 2022 Filed Aug 18, 2022 20:38 UTC
DUGGAN ROBERT WDirector · Chief Executive Officer
PurchaseCommon Stock 94,849,203 $0.97 $92,003,726.91
Disclosure

SEC source: 0001387131-22-008888 · duggan-form4_081622.xml · nonDerivative · entry 1

DUGGAN ROBERT W · CIK 0001055919 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,532,792

F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.

Read SEC document
August 16, 2022 Filed Aug 18, 2022 20:36 UTC
Zanganeh MahkamDirector · Co-CEO & President
PurchaseCommon Stock 1,030,925 $0.97 $999,997.25
Disclosure

SEC source: 0001387131-22-008886 · zangeneh-form4_081622.xml · nonDerivative · entry 3

Zanganeh Maky · CIK 0001507650 · Director · Co-CEO & President

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee.

Disclosed balance after: 3,135,466

F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.

F2 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
August 16, 2022 Filed Aug 18, 2022 20:36 UTC
Zanganeh MahkamDirector · Co-CEO & President
PurchaseCommon Stock 4,593,777 $0.97 $4,455,963.69
Disclosure

SEC source: 0001387131-22-008886 · zangeneh-form4_081622.xml · nonDerivative · entry 2

Zanganeh Maky · CIK 0001507650 · Director · Co-CEO & President

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee.

Disclosed balance after: 7,061,557

F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.

F2 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
August 16, 2022 Filed Aug 18, 2022 20:36 UTC
Zanganeh MahkamDirector · Co-CEO & President
PurchaseCommon Stock 184,430 $0.97 $178,897.10
Disclosure

SEC source: 0001387131-22-008886 · zangeneh-form4_081622.xml · nonDerivative · entry 1

Zanganeh Maky · CIK 0001507650 · Director · Co-CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 359,969

F1 · shares: Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.

Read SEC document
August 16, 2022 Filed Mar 8, 2023 21:58 UTC Amendment
Dhingra AnkurChief Financial Officer
PurchaseCommon Stock 24,658 $0.97 $23,918.26
Disclosure

SEC source: 0001849682-23-000002 · wf-form4a_167831269908577.xml · nonDerivative · entry 2

Dhingra Ankur · CIK 0001849682 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Dhingra Family Revocable Trust

Disclosed balance after: 38,196

F2 · balance_after: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
August 16, 2022 Filed Mar 8, 2023 21:58 UTC Amendment
Dhingra AnkurChief Financial Officer
PurchaseCommon Stock 13,027 $0.97 $12,636.19
Disclosure

SEC source: 0001849682-23-000002 · wf-form4a_167831269908577.xml · nonDerivative · entry 1

Dhingra Ankur · CIK 0001849682 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,527

F1 · shares: This Form 4 is being amended to correct the number of shares purchased by the Reporting Person in the Issuer's rights offering. 1,470 shares were inadvertently omitted from the original filing.

F1 · balance_after: This Form 4 is being amended to correct the number of shares purchased by the Reporting Person in the Issuer's rights offering. 1,470 shares were inadvertently omitted from the original filing.

Read SEC document
May 31, 2022 Filed Jun 2, 2022 21:29 UTC
Dhingra AnkurChief Financial Officer
GrantStock Option (right to buy) · Derivative 600,000 Not disclosed Strike: $1.33 Not disclosed
Disclosure

SEC source: 0001849682-22-000003 · wf-form4_165420535405545.xml · derivative · entry 1

Dhingra Ankur · CIK 0001849682 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Common Stock · 600,000 shares

Expires 2032-05-31

F2 · price: Not applicable.

F1 · derivative.exercise_date: The option was granted on May 31, 2022. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on May 31, 2023 (the one-year anniversary of the grant date).

Read SEC document
May 23, 2022 Filed May 26, 2022 00:45 UTC
DUGGAN ROBERT WDirector · Chief Executive Officer
OtherCommon Stock 21,135 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-22-064838 · tm2216975-1_4seq1.xml · nonDerivative · entry 1

DUGGAN ROBERT W · CIK 0001055919 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,683,589

F1 · kind: The shares of Common Stock were collateral for a loan made by the Reporting Person to a third party, and were transferred to the Reporting Person in full satisfaction of the loan.

F1 · price: The shares of Common Stock were collateral for a loan made by the Reporting Person to a third party, and were transferred to the Reporting Person in full satisfaction of the loan.

Read SEC document
April 25, 2022 Filed Apr 26, 2022 16:36 UTC
Gayko UrteDirector
GrantStock Option (right to buy) · Derivative 400,000 Not disclosed Strike: $1.93 Not disclosed
Disclosure

SEC source: 0001599298-22-000034 · wf-form4_165100539719830.xml · derivative · entry 1

Gayko Urte · CIK 0001559217 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires 2032-04-25

F2 · price: Not applicable.

F1 · derivative.exercise_date: The option was granted on April 25, 2022. The shares underlying the option are scheduled to vest in four equal annual installments over four years.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 16:07 UTC
Gayko UrteDirector
GrantStock Option (right to buy) · Derivative 42,553 $1.13 Strike: $2.82 $48,084.89
Disclosure

SEC source: 0001599298-22-000008 · wf-form4_164141681907145.xml · derivative · entry 2

Gayko Urte · CIK 0001559217 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,553

Underlying: Common Stock · 42,553 shares

Expires 2032-01-03

F4 · price: The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $48,000.

F3 · derivative.exercise_date: The option was issued on January 3, 2022. The shares underlying the option are scheduled to vest in four equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 16:07 UTC
Gayko UrteDirector
GrantStock Option (right to buy) · Derivative 25,000 Not disclosed Strike: $2.82 Not disclosed
Disclosure

SEC source: 0001599298-22-000008 · wf-form4_164141681907145.xml · derivative · entry 1

Gayko Urte · CIK 0001559217 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-01-03

F2 · price: Not applicable.

F1 · derivative.exercise_date: The option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 16:01 UTC GrantStock Option (right to buy) · Derivative 58,510 $1.13 Strike: $2.82 $66,116.30
Disclosure

SEC source: 0001599298-22-000005 · wf-form4_164141648612518.xml · derivative · entry 2

Clark Kenneth A · CIK 0001561736 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,510

Underlying: Common Stock · 58,510 shares

Expires 2032-01-03

F4 · price: The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $66,000.

F3 · derivative.exercise_date: The option was issued on January 3, 2022. The shares underlying the option are scheduled to vest in four equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 16:01 UTC GrantStock Option (right to buy) · Derivative 25,000 Not disclosed Strike: $2.82 Not disclosed
Disclosure

SEC source: 0001599298-22-000005 · wf-form4_164141648612518.xml · derivative · entry 1

Clark Kenneth A · CIK 0001561736 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-01-03

F2 · price: Not applicable.

F1 · derivative.exercise_date: The option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:03 UTC GrantStock Option (right to buy) · Derivative 82,446 $1.13 Strike: $2.82 $93,163.98
Disclosure

SEC source: 0001599298-22-000006 · wf-form4_164141659851379.xml · derivative · entry 2

Soni Manmeet Singh · CIK 0001569769 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,446

Underlying: Common Stock · 82,446 shares

Expires 2032-01-03

F4 · price: The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $93,000.

F3 · derivative.exercise_date: The option was issued on January 3, 2022. The shares underlying the option are scheduled to vest in four equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:03 UTC GrantStock Option (right to buy) · Derivative 25,000 Not disclosed Strike: $2.82 Not disclosed
Disclosure

SEC source: 0001599298-22-000006 · wf-form4_164141659851379.xml · derivative · entry 1

Soni Manmeet Singh · CIK 0001569769 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-01-03

F2 · price: Not applicable.

F1 · derivative.exercise_date: The option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:05 UTC GrantStock Option (right to buy) · Derivative 47,872 $1.13 Strike: $2.82 $54,095.36
Disclosure

SEC source: 0001599298-22-000007 · wf-form4_164141670774490.xml · derivative · entry 2

Mahatme Ujwala · CIK 0001823894 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,872

Underlying: Common Stock · 47,872 shares

Expires 2032-01-03

F4 · price: The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $54,000.

F3 · derivative.exercise_date: The option was issued on January 3, 2022. The shares underlying the option are scheduled to vest in four equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.